<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39465786</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>41</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Retrospective analysis of venous thromboembolism, arterial thromboembolism, and microthrombosis incidence at a single center during the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>e39915</StartPage><MedlinePgn>e39915</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39915</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000039915</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pneumonia caused by severe acute respiratory syndrome coronavirus 2 has posed a significant threat to global health since its outbreak in early 2020. Various thrombotic complications have been reported in COVID-19 cases. This study aims to investigate the incidence of various types of thromboses during the COVID-19 pandemic, and explore the potential correlation between the number of COVID-19 infections and occurrence of thrombosis. The present retrospective, single-center study recorded the number of new cases with various types of thromboembolism among all hospital admissions between 2019 and 2023 in a single center. The correlation between the number of total thromboembolism cases and number of inpatients who tested positive for COVID-19 was assessed using Spearman rank correlation coefficient. A total of 3926 thromboembolism cases were recorded in men, while 3657 cases were reported in women. The total number of new thromboembolism cases among all inpatients annually increased from 2019 to 2022, and reached a peak during the "full liberalization" period from December 2022 to January 2023. The most substantial increase was observed in microthrombosis cases, followed by venous and arterial thrombosis cases. In addition, thromboembolism primarily occurred in the lower extremities, followed by the abdomen. The fewest cases were observed in the upper extremities. Furthermore, the correlation coefficient between the total number of thromboembolism cases and number of COVID-19-positive patients between January 2020 and June 2023 was 0.501 (P = .001). The number of thromboembolism cases among all inpatients was correlated to the number of COVID-19-positive patients during the pandemic. Early thromboembolism prophylaxis and thrombotic complications monitoring should be considered for hospitalized patients, when necessary.</AbstractText><CopyrightInformation>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Wenjun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Anqing Municipal Hospital, Anqing City, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yuefeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Sir Run Run Shaw Hospital, Hangzhou, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Zongjie</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Anqing Municipal Hospital, Anqing City, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Canjun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anqing Municipal Hospital, Anqing City, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Anqing Municipal Hospital, Anqing City, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Haijun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Anqing Municipal Hospital, Anqing City, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Anqing Municipal Hospital, Anqing City, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Lisheng</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0004-8477-7825</Identifier><AffiliationInfo><Affiliation>Anqing Municipal Hospital, Anqing City, Anhui Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="Y">Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39465786</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000039915</ArticleId><ArticleId IdType="pii">00005792-202410110-00004</ArticleId><ArticleId IdType="pmc">PMC11479453</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jakovljevic M, Bjedov S, Jaksic N, Jakovljevic I. COVID-19 pandemia and public and global mental health from the perspective of global health securit. Psychiatr Danub. 2020;32:6–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">32303023</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323:1545–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167538</ArticleId></ArticleIdList></Reference><Reference><Citation>You Y, Yang X, Hung D, Yang Q, Wu T, Deng M. Asymptomatic COVID-19 infection: diagnosis, transmission, population characteristics. BMJ Support Palliat Care. 2021;14:e220–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">34330791</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022;322:C1–C11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JC. Novel classification of thrombotic disorders based on molecular hemostasis and thrombogenesis producing primary and secondary phenotypes of thrombosis. Biomedicines. 2022;10:2706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9687744</ArticleId><ArticleId IdType="pubmed">36359229</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal S, Quintili AL, Karamchandani K, Bose S. Thromboembolic disease in COVID-19 patients: a brief narrative review. J Intensive Care. 2020;8:70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487447</ArticleId><ArticleId IdType="pubmed">32939266</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BK, Mainbourg S, Friggeri A, et al. . Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax. 2021;76:970–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33622981</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigtlaender M, Edler C, Gerling M, et al. . Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: frequency, characteristics and risk factors. Thromb Res. 2022;218:171–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9420077</ArticleId><ArticleId IdType="pubmed">36057167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai Z, Li C, Chen Y, et al. . Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines. Thromb Haemost. 2020;120:937–48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295267</ArticleId><ArticleId IdType="pubmed">32316065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu P. China needs to improve its rural public health system to cope with the peak of COVID-19 infections. Asia Pac J Public Health. 2023;35:322–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10083712</ArticleId><ArticleId IdType="pubmed">37029543</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenner WJ, Kanji R, Mirsadraee S, et al. . Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review. J Thromb Thrombolysis. 2021;51:595–607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7882250</ArticleId><ArticleId IdType="pubmed">33586113</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip M, van der Meer NJM, et al. . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7:e438–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Duarte-Salles T, Fernandez-Bertolin S, et al. . Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis. 2022;22:1142–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9106320</ArticleId><ArticleId IdType="pubmed">35576963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu YF, Pan LY, Zhang WW, et al. . A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int J Infect Dis. 2020;100:34–41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7425668</ArticleId><ArticleId IdType="pubmed">32798659</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheruiyot I, Kipkorir V, Ngure B, Misiani M, Munguti J, Ogeng’o J. Arterial thrombosis in coronavirus disease 2019 patients: a rapid systematic review. Ann Vasc Surg. 2021;70:273–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453204</ArticleId><ArticleId IdType="pubmed">32866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Pan JY. Anatomical and pathological observation and analysis of SARS and COVID-19: microthrombosis is the main cause of death. Biol Proced Online. 2021;23:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816139</ArticleId><ArticleId IdType="pubmed">33472576</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman IA, Ye K, Scheinfeld MH. Lower-extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death. Radiology. 2020;297:E263–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370378</ArticleId><ArticleId IdType="pubmed">32673190</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Qiu Y, Cao J, et al. . Ultrasound features of abdominal thrombosis in COVID 19 patients. Clin Hemorheol Microcirc. 2022;82:239–48.</Citation><ArticleIdList><ArticleId IdType="pubmed">35811512</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcos-Jubilar M, Lecumberri R, Páramo JA. Immunothrombosis: molecular aspects and new therapeutic perspectives. J Clin Med. 2023;12:1399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9958829</ArticleId><ArticleId IdType="pubmed">36835934</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang XZ, Wang YX, Xu JQ, He YJ, Peng ZK, Shang Y. Immunothrombosis in acute respiratory dysfunction of COVID-19. Front Immunol. 2021;12:651545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8207198</ArticleId><ArticleId IdType="pubmed">34149692</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepehrinezhad A, Gorji A, Sahab Negah S. SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism. Inflammopharmacology. 2021;29:1049–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266993</ArticleId><ArticleId IdType="pubmed">34241783</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Chang W, Zhang L, Zhang Y. Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19. Int J Biol Sci. 2022;18:5827–48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9576507</ArticleId><ArticleId IdType="pubmed">36263178</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18:666–82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8100938</ArticleId><ArticleId IdType="pubmed">33958774</ArticleId></ArticleIdList></Reference><Reference><Citation>Otifi HM, Adiga BK. Endothelial dysfunction in Covid-19 Infection. Am J Med Sci. 2022;363:281–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8802031</ArticleId><ArticleId IdType="pubmed">35093394</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Swieringa F, Spronk HMH, Heemskerk JWM, van der Meijden PEJ. Integrating platelet and coagulation activation in fibrin clot formation. Res Pract Thromb Haemost. 2018;2:450–60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6046596</ArticleId><ArticleId IdType="pubmed">30046749</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE. Neutrophil extracellular traps (NETs) and Covid-19: a new frontiers for therapeutic modality. Int Immunopharmacol. 2022;104:108516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8733219</ArticleId><ArticleId IdType="pubmed">35032828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Shi H, et al. . Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5:e138999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>